These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6543695

  • 1. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
    Giraldi T, Sava G, Cherubino R, Bottiroli G, Mazzini G.
    Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
    [Abstract] [Full Text] [Related]

  • 2. Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice.
    Giraldi T, Houghton PJ, Taylor DM, Nisi C.
    Cancer Treat Rep; 1978 May; 62(5):721-5. PubMed ID: 657157
    [Abstract] [Full Text] [Related]

  • 3. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Mitri E, Cherubino R.
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [Abstract] [Full Text] [Related]

  • 4. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G, Giraldi T, Zupi G, Sacchi A.
    Invasion Metastasis; 1984 Jul; 4(3):171-8. PubMed ID: 6480289
    [Abstract] [Full Text] [Related]

  • 5. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L.
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T, D'Incalci M.
    Cancer Chemother Pharmacol; 1984 Jun; 13(2):139-41. PubMed ID: 6467499
    [Abstract] [Full Text] [Related]

  • 10. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G, Giraldi T, Lassiani L, Nisi C.
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G, Giraldi T, Nisi C, Bertoli G.
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic activity of ICRF-159 combined with surgery: effects of postsurgical treatment with cyclophosphamide in mice bearing Lewis lung carcinoma lines.
    Sava G, Zorzet S, Perissin L.
    Anticancer Res; 1985 Jan; 5(5):511-5. PubMed ID: 4062252
    [Abstract] [Full Text] [Related]

  • 14. Combination of radiation and razoxane (ICRF 159) in vivo.
    Hellmann K, Grimshaw MB, Hutchinson GE.
    Int J Radiat Oncol Biol Phys; 1978 Jan; 4(1-2):109-13. PubMed ID: 632139
    [No Abstract] [Full Text] [Related]

  • 15. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
    Witiak DT, Lee HJ, Goldman HD, Zwilling BS.
    J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G, Cavallari A, Greco C, Sacchi A.
    Anticancer Res; 1984 Dec; 4(1-2):91-5. PubMed ID: 6712181
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.